Pharmafile Logo

Peter Impey

Heather Desmet appointed new Head of Living With

We are delighted to welcome Heather Desmet as Head of Living With at the company’s London headquarters.

Inizio

Webinar Recording: The Art of Storytelling in Pharma Market Research

Effectively communicating research insights is a major focus for today’s market researcher, particularly in global healthcare. It’s not enough now just to present the research evidence. We must tell the...

Inizio

Video: Conducting mobile conference research

Our digital expert, Director John Branston explores how a mobile approach offers a better way of evaluating the impact of your conference presence

Inizio

No one needs to go hungry in London

Our Say blogger returns to St James’s Church Winter Shelter for an overnight shift for the West London Day Centre charity.

Say Communications

- PMLiVE

Rare diseases: Regulatory and reimbursement submissions, the challenges

Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

Issues facing brand teams and how agencies help to deliver value

We interviewed Wayne Atherden, Procurement Director Commercial Services at Janssen, to get his view on the issues facing brand teams and how agencies help to deliver value.

Blue Latitude Health

- PMLiVE

As CEO returns, Valeant admits SEC probe

Embattled firm's problems continue

Gilead Sciences

Gilead wins US approval for second TAF-based HIV drug

FDA gives Odefsey the green light

- PMLiVE

Cello Health boosts senior leadership team

Jon Bircher, Isaac Batley and Steve Smith take on new roles 

Bo Jesper Hansen to step down as chairman of Sobi

Håkan Björklund will be nominated as his replacement

- PMLiVE

Beyond the patient journey: Designing for behaviour change

In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.

Blue Latitude Health

Roche Basel Switzerland

Roche chalks up second approval for Gazyva

FDA approves additional indication as a treatment for follicular lymphoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links